XML 66 R51.htm IDEA: XBRL DOCUMENT v3.22.2
Basis of Presentation, Summary of Significant Accounting Policies and Change in Accounting Principles - Restricted Cash and Restricted Investments (Details) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Jun. 30, 2021
Dec. 31, 2020
Restricted Cash and Cash Equivalents Items [Line Items]        
Restricted funds   $ 88,662    
Current restricted cash $ 74,377 75,685    
Total current restricted cash and restricted investments 74,377 75,685    
Non-current restricted cash 12,986 12,977    
Total non-current restricted cash and restricted investments 12,986 12,977    
Cash and cash equivalents 193,070   $ 207,273  
Restricted cash and restricted investments 87,363   31,137  
Total cash and cash equivalents and restricted cash shown in the consolidated statements of cash flows [1] 280,433 354,942 $ 238,410 $ 361,581
Collateral for letters of credit for facility leases        
Restricted Cash and Cash Equivalents Items [Line Items]        
Restricted funds 2,269 3,769    
Collateral with financial institutions        
Restricted Cash and Cash Equivalents Items [Line Items]        
Restricted funds 11,504 11,662    
Claims processing services        
Restricted Cash and Cash Equivalents Items [Line Items]        
Restricted funds 73,585 73,226    
Other        
Restricted Cash and Cash Equivalents Items [Line Items]        
Restricted funds 5 5    
Bank time deposits        
Restricted Cash and Cash Equivalents Items [Line Items]        
Restricted funds $ 11,500 $ 11,700    
[1] As a result of the closing of the sale of True Health during the first quarter of 2021, the consolidated statement of operations and related financial information reflect the Company’s operations and assets and liabilities of True Health as discontinued operations. Cash flows and comprehensive income have not been adjusted and are included in the consolidated statements of cash flows and consolidated statements of comprehensive income (loss) for the six months ended June 30, 2021. See Note 5.